Gender differences and in-hospital mortality in patients undergoing percutaneous coronary interventions

Agnieszka Nowakowska-Arendt1, Zofia Grabczewska, Marek Koziński

  • 1Department of Cardiology and Internal Diseases, A Jurasza University Hospital, Bydgoszcz, Poland.

Kardiologia Polska
|July 16, 2008
PubMed

Insights

Percutaneous coronary intervention (PCI) outcomes in women with coronary artery disease (CAD) show differences compared to men, particularly in acute myocardial infarction (AMI) cases. Cardiogenic shock is a key mortality factor for women post-PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Services Research

Background:

  • Observational studies indicate women receive less invasive coronary artery disease (CAD) treatment and have poorer percutaneous coronary intervention (PCI) outcomes than men.
  • Existing research suggests gender-based disparities in CAD diagnosis and treatment referrals.

Purpose of the Study:

  • To directly compare the outcomes of percutaneous coronary intervention (PCI) between male and female patients.
  • To identify demographic, angiographic, and clinical factors influencing hospitalization duration and in-hospital mortality in men and women undergoing PCI.

Main Methods:

  • Retrospective analysis of 1000 consecutive patients undergoing PCI for acute myocardial infarction (AMI), unstable angina (UA), or stable angina (SA).
  • Examination of demographic data, clinical variables, and angiographic findings.
  • Comparative analysis of hospitalization duration and in-hospital mortality stratified by gender and reason for PCI.

Main Results:

  • Women, constituting 25.8%-39.6% of PCI patients, were older with higher BMI and more comorbidities (hypertension, diabetes).
  • Hospitalization duration was similar for SA/UA but longer for women with AMI.
  • While gender itself didn't impact mortality in univariate analysis, multivariate analysis revealed female gender, age, BMI, diabetes, hypercholesterolemia, PCI indication, final TIMI flow, and cardiogenic shock affected mortality. Cardiogenic shock was the sole significant factor for women, whereas men were affected by PCI indication, age, diabetes, and final TIMI flow.

Conclusions:

  • Stable angina (SA) is a less frequent indication for PCI in women compared to men.
  • Women with CAD present older and with more cardiovascular risk factors.
  • In-hospital mortality post-PCI for SA is gender-independent; cardiogenic shock is the primary mortality determinant in women, while men's mortality is influenced by PCI indication, diabetes, and vessel flow.
Abstract

Related Concept Videos

Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...